Skip to content

To the study the effect of a herbal nasal spray along with internal medicine in managing the symptoms of Allergic rhinitis

Efficacy of Parnayavani arkam nasal spray as an add-on to Haridra Khandam in the management of Allergic Rhinitis- A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101330
Enrollment
40
Registered
2026-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

Vaidyaratnam Ayurveda College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants in the age group 18 to 50 irrespective of gender with Total Nasal Symptom Score greater than 4. 2. Symptoms present for more than 2 days a week. 3. Elevated IgE levels greater than 100 IU PER ML

Exclusion criteria

Exclusion criteria: 1. Previous history of Bronchial Asthma, Tuberculosis and any other lungs related disease. 2. Participants with chronic sinusitis. 3. Cases requiring surgical treatment such as nasal polyp. 4. Participants with Hyper immunoglobin E syndrome 5. Participants who are currently under medications like antihistamines, corticosteroids etc. 6. Pregnant women and Lactating Mothers. 7. Participants having completed any other trial within the past 6 months.

Design outcomes

Primary

MeasureTime frame
1.Total Nasal Symptom Score 2.Rhino conjunctivitis Quality of Life Questionnaire Objective parameters 3.Total Lymphocyte Count 4.Erythrocyte sedimentation Rate 5.Absolute Eosinophil Count 6.Serum IgETimepoint: Day 0,Day 7,Day 16,Day 31

Secondary

MeasureTime frame
Rhino conjunctivitis Quality of Life QuestionnaireTimepoint: Day 0, Day 16, Day 31

Countries

India

Contacts

Public ContactDr T C Marikutty

Vaidyaratnam Ayurveda College

drmarikuttytc@gmail.com9447829212

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026